Evidence map›Paper›PMID 37285353›Full record

ArticlePloS one2023

gUMI-BEAR, a modular, unsupervised population barcoding method to track variants and evolution at high resolution.

Shahar Rezenman, Maor Knafo, Ivgeni Tsigalnitski, Shiri Barad, Ghil Jona, Dikla Levi, Orly Dym, Ziv Reich, Ruti Kapon

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shahar RezenmanDepartment of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel.
Maor KnafoDepartment of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel.ORCID 0000-0002-3800-4555
Ivgeni TsigalnitskiDepartment of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel.
Shiri BaradDepartment of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel.
Ghil JonaLife Sciences Core Facilities, Weizmann Institute of Science Rehovot, Rehovot, Israel.ORCID 0000-0002-4526-6182
Dikla LeviLife Sciences Core Facilities, Weizmann Institute of Science Rehovot, Rehovot, Israel.
Orly DymThe Dana and Yossie Hollander Center for Structural Proteomics, Weizmann Institute of Science Rehovot, Rehovot, Israel.
Ziv ReichDepartment of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel.
Ruti KaponDepartment of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel.ORCID 0000-0002-0618-6470

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular lineage tracking provides a means to observe population makeup at the clonal level, allowing exploration of heterogeneity, evolutionary and developmental processes and individual clones' relative fitness. It has thus contributed significantly to understanding microbial evolution, organ differentiation and cancer heterogeneity, among others. Its use, however, is limited because existing methods are highly specific, expensive, labour-intensive, and, critically, do not allow the repetition of experiments. To address these issues, we developed gUMI-BEAR (genomic Unique Molecular Identifier Barcoded Enriched Associated Regions), a modular, cost-effective method for tracking populations at high resolution. We first demonstrate the system's application and resolution by applying it to track tens of thousands of Saccharomyces cerevisiae lineages growing together under varying environmental conditions applied across multiple generations, revealing fitness differences and lineage-specific adaptations. Then, we demonstrate how gUMI-BEAR can be used to perform parallel screening of a huge number of randomly generated variants of the Hsp82 gene. We further show how our method allows isolation of variants, even if their frequency in the population is low, thus enabling unsupervised identification of modifications that lead to a behaviour of interest.

Indexed as

NeoplasmsClone CellsGenomeHumans

Identifiers

PMID37285353
PMCPMC10246843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.